WHO Executive Board Meeting Discusses Consensus On R&D For Neglected Diseases

Intellectual Property Watch reports on discussions at the ongoing WHO Executive Board meeting “over legal and political aspects of a consensus reached by a small number of member states in November on implementing a plan to address the global lack of research and development [R&D] for neglected diseases predominantly afflicting poor populations.” The news service writes, “A top issue for the week is the longstanding public health policy problem of finding ways to stimulate R&D on treatments for diseases for which there is little incentive for the private sector to invest, since they traditionally recoup their R&D costs through high prices on the resulting medicines.” IP Watch describes the outcomes of a November 2012 meeting to discuss the issue, writing, “This compromise outcome disappointed a number of member states and public health advocates who have been working on this issue at WHO for many years leading up to this point and hoped for a more ambitious plan.” The news service describes the ongoing debate (New, 1/28).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.